Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial.
Thomas H MarwickElizabeth DewarMark NolanMitra ShiraziPeter DiasLeah WrightBen FitzgeraldLeighton KearneyPiyush SrivastavaJohn AthertonKazuaki NegishiAaron L SverdlovSudhir WahiJames OttonJoseph SelvanayagamLiza ThomasPaaladinesh Thavendiranathannull nullPublished in: European heart journal (2024)
In patients with isolated GLS reduction after anthracyclines, cardioprotection is associated with better preservation of 12-month MRI-LVEF compared with usual care.